These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31387554)

  • 1. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
    Nam KH; Yi SA; Nam G; Noh JS; Park JW; Lee MG; Park JH; Oh H; Lee J; Lee KR; Park HJ; Lee J; Han JW
    BMC Cancer; 2019 Aug; 19(1):773. PubMed ID: 31387554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.
    Jeong S; Park H; Hong S; Yum S; Kim W; Jung Y
    Eur J Pharmacol; 2015 Jan; 747():114-22. PubMed ID: 25483211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
    Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosmarinic Acid Methyl Ester Regulates Ovarian Cancer Cell Migration and Reverses Cisplatin Resistance by Inhibiting the Expression of Forkhead Box M1.
    Lim SH; Nam KH; Kim K; Yi SA; Lee J; Han JW
    Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33053721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
    Alam A; Khan MS; Mathur Y; Sulaimani MN; Farooqui N; Ahmad SF; Nadeem A; Yadav DK; Mohammad T
    J Biomol Struct Dyn; 2024 Jul; 42(11):5758-5769. PubMed ID: 37365756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer.
    Leisching GR; Loos B; Botha MH; Engelbrecht AM
    Toxicology; 2015 Sep; 335():72-8. PubMed ID: 26201060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constituents of Mediterranean Spices Counteracting Vascular Smooth Muscle Cell Proliferation: Identification and Characterization of Rosmarinic Acid Methyl Ester as a Novel Inhibitor.
    Liu R; Heiss EH; Waltenberger B; Blažević T; Schachner D; Jiang B; Krystof V; Liu W; Schwaiger S; Peña-Rodríguez LM; Breuss JM; Stuppner H; Dirsch VM; Atanasov AG
    Mol Nutr Food Res; 2018 Apr; 62(7):e1700860. PubMed ID: 29405576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway.
    Wu T; Wang MC; Jing L; Liu ZY; Guo H; Liu Y; Bai YY; Cheng YZ; Nan KJ; Liang X
    Drug Des Devel Ther; 2015; 9():6421-31. PubMed ID: 26715839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosmarinic Acid Methyl Ester Inhibits LPS-Induced NO Production via Suppression of MyD88- Dependent and -Independent Pathways and Induction of HO-1 in RAW 264.7 Cells.
    So Y; Lee SY; Han AR; Kim JB; Jeong HG; Jin CH
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27548124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726, the active metabolite of leflunomide, induces autophagy through TAK1-mediated AMPK and JNK activation.
    Xu X; Sun J; Song R; Doscas ME; Williamson AJ; Zhou J; Sun J; Jiao X; Liu X; Li Y
    Oncotarget; 2017 May; 8(18):30438-30454. PubMed ID: 28389629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting MCL1 with Sanggenon C overcomes MCL1-driven adaptive chemoresistance via dysregulation of autophagy and endoplasmic reticulum stress in cervical cancer.
    Sun W; Cai H; Zhang K; Cui H; Zhao E
    Phytomedicine; 2024 Oct; 133():155935. PubMed ID: 39126925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
    He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH
    Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin.
    Dhar R; Basu A
    Int J Oncol; 2008 May; 32(5):1133-7. PubMed ID: 18425342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3β axis.
    Huang L; Chen J; Quan J; Xiang D
    Bioengineered; 2021 Dec; 12(1):3065-3076. PubMed ID: 34224305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells.
    Wu CF; Hong C; Klauck SM; Lin YL; Efferth T
    J Ethnopharmacol; 2015 Dec; 176():55-68. PubMed ID: 26476154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway.
    Jiang S; Chang H; Deng S; Fan D
    Int J Oncol; 2019 Jun; 54(6):1933-1942. PubMed ID: 31081049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway.
    Liao XZ; Gao Y; Sun LL; Liu JH; Chen HR; Yu L; Chen ZZ; Chen WH; Lin LZ
    Phytother Res; 2020 May; 34(5):1142-1153. PubMed ID: 31985119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of pharmacophore hypothesis, genetic function approximation model, and molecular docking to identify novel inhibitors of S6K1.
    Zhang H; Xiang ML; Liang JY; Zeng T; Zhang XN; Zhang J; Yang SY
    Mol Divers; 2013 Nov; 17(4):767-72. PubMed ID: 23982212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytotoxic concentration of rosmarinic acid increases MG132-induced cytotoxicity, proteasome inhibition, autophagy, cellular stresses, and apoptosis in HepG2 cells.
    Ozgun GS; Ozgun E
    Hum Exp Toxicol; 2020 Apr; 39(4):514-523. PubMed ID: 31876192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.